Theseus Pharmaceuticals Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	-2,354	-49	-892	2,011	8,137	1,582	Upgrade
Depreciation & Amortization	7,232	7,389	7,441	8,796	8,397	9,359	Upgrade
Other Amortization	1,410	1,410	1,356	-	-	-	Upgrade
Other Operating Activities	4,485	2,244	3,744	956	-6,266	2,255	Upgrade
Operating Cash Flow	10,778	10,994	11,649	11,763	10,268	13,196	Upgrade
Operating Cash Flow Growth	-2.75%	-5.62%	-0.97%	14.56%	-22.19%	-12.16%	Upgrade
Capital Expenditures	-5,754	-5,790	-6,161	-6,350	-6,728	-7,529	Upgrade
Sale of Property, Plant & Equipment	269	269	310	842	564	509	Upgrade
Cash Acquisitions	-285	-189	-252	-1,628	-414	-79	Upgrade
Divestitures	941	220	1,004	-115	13,369	81	Upgrade
Investment in Securities	-496	-90	256	-303	-98	-25	Upgrade
Other Investing Activities	505	357	557	2,227	-797	-747	Upgrade
Investing Cash Flow	-4,820	-5,223	-4,286	-5,327	5,896	-7,790	Upgrade
Long-Term Debt Issued	-	3,547	2,674	2,585	3,646	8,527	Upgrade
Long-Term Debt Repaid	-	-4,406	-5,489	-8,614	-11,775	-11,367	Upgrade
Net Debt Issued (Repaid)	-1,374	-859	-2,815	-6,029	-8,129	-2,840	Upgrade
Issuance of Common Stock	913	-	-	-	-	-	Upgrade
Repurchase of Common Stock	-	-58	-223	-365	-478	-223	Upgrade
Common Dividends Paid	-1,679	-1,720	-1,701	-959	-617	-825	Upgrade
Other Financing Activities	-2,348	-2,035	-2,447	-572	-3,766	-1,550	Upgrade
Financing Cash Flow	-4,488	-4,672	-7,186	-7,925	-12,990	-5,438	Upgrade
Foreign Exchange Rate Adjustments	-245	-191	-258	156	-179	-402	Upgrade
Miscellaneous Cash Flow Adjustments	-19	3	-13	-2	-19	-4	Upgrade
Net Cash Flow	1,201	911	-94	-1,335	2,976	-438	Upgrade
Free Cash Flow	5,024	5,204	5,488	5,413	3,540	5,667	Upgrade
Free Cash Flow Growth	-5.63%	-5.17%	1.39%	52.91%	-37.53%	-14.29%	Upgrade
Free Cash Flow Margin	12.30%	12.35%	13.24%	13.28%	9.01%	12.89%	Upgrade
Free Cash Flow Per Share	1.04	0.92	0.97	0.94	0.60	0.95	Upgrade
Cash Income Tax Paid	668	668	454	92	459	509	Upgrade
Levered Free Cash Flow	4,188	4,153	5,020	2,792	12,243	-7,123	Upgrade
Unlevered Free Cash Flow	5,603	5,595	6,296	4,005	13,221	-6,177	Upgrade
Change in Net Working Capital	85	275	-2,191	515	-10,115	10,917	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.